Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
0/100
Pipeline Velocity
0/100
Trial Completion Rate
33/100
Pipeline Concentration
100/100
Pipeline Freshness
N/A
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Regulatory
Elitek — ELITEK
Application BLA103946 (BLA)
APIDRA — APIDRA
Application BLA021629 (BLA)
ZALTRAP — ZALTRAP
Application BLA125418 (BLA)
TOUJEO — TOUJEO
Application BLA206538 (BLA)
Kevzara — KEVZARA
Application BLA761037 (BLA)
Dupixent — Dupixent
Application 761055 (BLA)
Dupixent — DUPIXENT
Application BLA761055 (BLA)
Sarclisa — SARCLISA
Application BLA761113 (BLA)
ELREXFIO — ELREXFIO
Application BLA761345 (BLA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)